11 Agosto 2025

Recrutamento de primeiro doente assinala um marco importante num ensaio clínico, sobre o uso de psilocibina para efeitos terapêuticos, financiado pela UE

“Este é um passo histórico”, afirma Robert Schoevers, director do serviço de Psiquiatria do Centro Médico Universitário de Groningen (UMCG) e investigador principal do PsyPal. “Após muitos meses de preparação, estamos entusiasmados por começar a trabalhar directamente com doentes.”

Maria João Cardoso

04 Ago. 2025

Physiotherapist

Research
Início da Candidatura: 04 Ago. 2025

THIS RECRUITMENT PROCESS IS CLOSED.

 

04 Ago. 2025

Research Technician

Research
Início da Candidatura: 04 Ago. 2025

[PLEASE NOTE THAT THE RECRUITMENT PROCESS FOR THIS CALL IS NOW CLOSED]

Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud (Champalimaud Foundation), a private, non-profit research institution, is opening a call for a Research Technician.

Inês Faria

Gleb Gorodetskiy

Cátia Ramos

Heitor Munhoz Österdahl

Psychedelic Therapy: From Evidence to Equity

This one-day event will bring together clinicians, researchers, patient representatives, policymakers and ethicists to explore the landscape of psychedelic-assisted care through the lens of the four pillars of medical ethics: beneficence, autonomy, non-maleficence, and justice.

The symposium will delve into safety, regulation, therapeutic practices, and future directions to ensure equitable access to psychedelic-assisted care.

Medica AI 2026

Healthcare is entering a decisive decade.

Artificial Intelligence (AI) is no longer a promise on the horizon – it is already transforming diagnostics, treatment, research, education and health systems worldwide. The real challenge we now face is not whether AI will change healthcare, but how we design that transformation responsibly, sustainably and at scale.

Subscribe to Investigadores
Loading
Por favor aguarde...